KinomeScan

KINOMEscan™ Technology

Request a Quote Explore Our Panel

The Industry’s Most Comprehensive Kinase Profiling Service

KINOMEscan™ is an innovative, high-throughput method for screening small molecule compounds against large numbers of human kinases. By providing a fast, accurate, uniform and quantitative kinase profile that details how well each compound binds to both intended and unintended targets, KINOMEscan™ transforms the promiscuity of kinase inhibitors into a discovery advantage.

How it works

KINOMEscan™ is an active-site dependent competition binding assay in which human kinases of interest are fused to a proprietary tag. The amount of kinase bound to an immobilized, active-site directed ligand is measured in the presence and absence of the test compound.

New! Multiple Screening Options Available

scanMAX (402): Best choice for drug discovery and compound optimization
Definitive set of 402 kinases – the largest panel commercially available – covering all major kinase groups.
PDF [view list]    [Request a scanMAX quote - no obligation]

scanEDGE (96): An economical approach to surveying the human kinome
Contains a set of 96 kinases distributed throughout the kinome.
PDF [view list]    [Request a scanEDGE quote - no obligation]

scanTK (117): The world's most complete collection of Tyrosine Kinases
PDF [view list]    [Request a scanTK custom quote - no obligation]

scanELECT: Ultimate flexibility for custom applications
An a-la-carte approach to exploring kinases of interest. Choose only the kinases you want.
[Request a scanELECT custom quote - no obligation]

Binding Constant (Kd) Determination: Quantitative affinity measurement (11-point curve)
Can be determined for any kinase/compound combination using Ambit’s competition binding assay
[get more information]

Library Screening and Annotation: Get more from your compound libraries
Rapidly and inexpensively screen hundreds or thousands of compounds against any Ambit kinase panel.
[get more information]

The KINOMEscan™ Advantage

  • Fast – Two-week turnaround
  • Accurate – Compounds tested under uniform conditions
  • Economical – Most screens delivered for under $10 per kinase per compound
  • Consistent - Outstanding data reliability
  • Confidential – All data blinded and protected